Innovation in PALTC

(MO19) Do No PHarm: Achieve Deprescribing Success through Person-Centered Communication Strategies

Monday, March 11, 2024

3:30 PM – 5:00 PM CT

Room: 302

CME: (1.5) MOC: (1.5) CMD Management: (1.5) NP Pharmacology Hours (1.5)

Session Chair/Speaker(s)

MB

Magdalena Bednarczyk, MD

Division Chief, Geriatric Medicine and Palliative Care
Rush University Medical Center
Chicago, Illinois

Disclosure(s): No financial relationships to disclose.

Speaker(s)

Nivedita Gunturi, MD

Assistant Professor
Rush University Medical Center
Chicago, IL

Disclosure(s): No financial relationships to disclose.
Alexander Sasha Rackman, MD

Florida Atlantic University
Boca Raton, FL

Disclosure(s): No financial relationships to disclose.
Andrea J. Landi, MD (she/her/hers)

Assistant Professor
University of Chicago
Chicago, IL

Disclosure(s): No financial relationships to disclose.

Disclosure(s):

Magdalena Bednarczyk, MD: No financial relationships to disclose.

Nivedita Gunturi, MD: No financial relationships to disclose.

Alexander Sasha Rackman, MD: No financial relationships to disclose.

Andrea J. Landi, MD: No financial relationships to disclose.

This session will review common geriatric syndromes and the cognitive and functional assessments used in deprescribing efforts. This session will review high yield polypharmacy tools as well as training in FRAME, a person-centered deprescribing conversation framework. Case-based patient scenarios will be utilized to demonstrate appropriate medication management and polypharmacy reduction based on functional and cognitive assessment, and estimated life expectancy. Strategies for reducing anti-psychotic, benzodiazepine, opioid and anticoagulant medication use will be discussed, with a lens on disparities in this arena. In this workshop, interprofessional small groups will have the opportunity to practice facilitating person-centered deprescribing conversations.

Learning Objectives:

At the completion of this session, learners will be able to:

Describe how common geriatric syndromes, and cognitive and functional decline can adversely impact patients in terms of drug-drug and drug-disease interaction.
Attain familiarity with common polypharmacy identification and prognostication tools.
Utilize case-based scenarios of diverse patients experiencing functional and cognitive decline, frailty syndromes or multiple geriatric syndromes to illustrate important teaching points of polypharmacy identification and deprescribing strategies
Develop a framework for utilizing these tools and assessments, in addition to high yield communication strategies for successful deprescribing efforts